Indian pharma stocks tumble amid US tariff concerns
With a large portion of pharma revenues coming from US exports, the risk of increased tariffs has led to margin worries and market pullback. Indian pharmaceutical industry is particularly vulnerable […]
Zydus Lifesciences’ ‘Easiest Exam’ Campaign a Public Health Initiative in Breast Cancer Awareness reaches millions, wins accolades
Campaign empowers women to prioritise their health through thought provoking films, influencer-led campaigns, Scientific and medical podcasts, survivor experiences, and digital awareness National, India, May 26, 2025 Zydus Lifesciences’ nationwide […]
Zydus receives final approval from USFDA for Glatiramer Acetate Injection, the generic version of Copaxone® 20 mg/ml, 40 mg/ml, Single-Dose Prefilled Syringes
Ahmedabad, India, 08 May, 2025 Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and Drug Administration (USFDA) […]